Evidence map›Paper›PMID 38699264›Full record

ArticleChemical science2024

Fine-tuning of stable organic free-radical photosensitizers for photodynamic immunotherapy.

Xiang Wang, Gaona Shi, Rao Wei, Meng Li, Qingyang Zhang, Tiantai Zhang, Chuan-Feng Chen, Hai-Yu Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Smart molecules : open access · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiang WangState Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China haiyu.hu@imm.ac.cn ttzhang@imm.ac.cn.
Gaona ShiState Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China haiyu.hu@imm.ac.cn ttzhang@imm.ac.cn.
Rao WeiState Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China haiyu.hu@imm.ac.cn ttzhang@imm.ac.cn.
Meng LiBeijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences Beijing 100190 China cchen@iccas.ac.cn.ORCID https://orcid.org/0000-0003-4835-9293
Qingyang ZhangState Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China haiyu.hu@imm.ac.cn ttzhang@imm.ac.cn.ORCID https://orcid.org/0000-0003-4953-9536
Tiantai ZhangState Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China haiyu.hu@imm.ac.cn ttzhang@imm.ac.cn.
Chuan-Feng ChenBeijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences Beijing 100190 China cchen@iccas.ac.cn.ORCID https://orcid.org/0000-0002-4347-1406
Hai-Yu HuState Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China haiyu.hu@imm.ac.cn ttzhang@imm.ac.cn.ORCID https://orcid.org/0000-0002-4760-6865

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic immunotherapy (PDI) is an innovative approach to cancer treatment that utilizes photodynamic therapy (PDT) and photosensitizers (PSs) to induce immunogenic cell death (ICD). However, currently most commonly used PSs have restricted capabilities to generate reactive oxygen species (ROS)

Identifiers

PMID38699264
PMCPMC11062115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.